Antonella Naldini
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: September 06, 2011
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks.
Journal: Thrombosis and haemostasis
Published: May 10, 2011
Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1α and lipopolysaccharide.
Journal: Journal of cellular physiology
Published: March 31, 2011
Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 26, 2010
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells.
Journal: Journal of leukocyte biology
Published: November 06, 2009
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 06, 2008
A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues.
Journal: Diagnostic molecular pathology : the American journal of surgical pathology, part B
Published: August 28, 2007
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 20, 2006
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes.
Journal: Journal of leukocyte biology
Published: June 18, 2005
Role of inflammatory mediators in angiogenesis.
Journal: Current drug targets. Inflammation and allergy
Published: February 22, 2005
The thrombin peptide, TP508, enhances cytokine release and activates signaling events.
Journal: Peptides
Published: February 04, 2004
Last Updated: 09/26/2026